Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI &a; software, and deep tech.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 46 Woodstock Road
City: Oxford
State: england
Zip: OX2 6HT
Country: GB
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2018 | OMass Technologies | Series A | 17.9M |
6/2016 | OMass Technologies | Seed Round | 1.4M |
1/2018 | Bodle Technologies | Series A | 8.5M |
12/2020 | T-Cypher Bio | Seed Round | - |
2/2020 | OMass Technologies | Series A | 35.8M |
1/2023 | Oxford Ionics | Series A | 0 |
9/2011 | Oxtex | Seed Round | 800k |
2/2016 | Mind Foundry | Seed Round | 1.7M |
1/2018 | Vaccitech | Series A | 0 |
1/2021 | Theolytics | Series A | 6.8M |
9/2017 | Mind Foundry | Seed Round | 3.4M |
11/2022 | Osler Diagnostics | Series C | 0 |
9/2017 | Oxford Quantum Circuits | Series A | - |
4/2017 | ONI | Seed Round | 3.7M |
8/2018 | Genomics | Series B | 32.5M |
11/2018 | OxMet Technologies | Series A | 7.8M |
6/2017 | Zegami | Series A | 3M |
10/2022 | Nucleome Therapeutics | Series A | 42.3M |
9/2018 | Oxford VR | Seed Round | 4.2M |
4/2020 | Living Optics | Seed Round | 4.1M |
3/2017 | Pro-Mapp | Seed Round | - |
5/2022 | MoA Technology | Series B | 0 |
3/2018 | 6D.ai | Seed Round | - |
4/2021 | Oxford Endovascular | Series A | 0 |
2/2021 | SpyBiotech | Series A | 32.5M |
11/2020 | Refeyn | Series A | 30M |
8/2021 | Ultromics | Series B | 0 |
9/2019 | YASA | Series C | 22.2M |
12/2017 | Navenio | Funding Round | 7.7M |
5/2020 | Navenio | Series A | 0 |
8/2018 | BioBeats | Seed Round | 3M |
2/2023 | Quantum Motion | Series B | 0 |
5/2020 | Quantum Motion Technologies | Series A | 9.8M |
12/2017 | Theolytics | Seed Round | 3.4M |
4/2022 | OMass Technologies | Series B | 0 |
11/2016 | Vaccitech | Seed Round | 12.4M |
5/2017 | Ultromics | Seed Round | 2.6M |
5/2016 | Evox Therapeutics | Series A | 14.4M |
8/2017 | OxMet Technologies | Seed Round | 2.6M |
2/2022 | First Light Fusion | Series C | 45M |
12/2016 | EnzBond | Seed Round | 445.3k |
6/2020 | Oxford Ionics | Seed Round | 3.4M |
12/2021 | Alethiomics | Seed Round | 8M |
1/2016 | Oxford Flow | Seed Round | - |
6/2022 | ORCA Computing | Series A | 15M |
3/2016 | Diffblue | Seed Round | - |
10/2016 | DJS Antibodies | Seed Round | - |
5/2019 | Albus Health | Convertible Note | 580.9k |
3/2017 | Oxford Semantic Technologies | Seed Round | - |
7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
9/2018 | Oxford VR | Venture Round | 4.2M |
6/2017 | Scenic Biotech | Series A | 7.3M |
8/2018 | Edplus | Pre Seed Round | 643.5k |
5/2021 | Omega Crop | Seed Round | 1.7M |
12/2018 | Genomics | Series B | 9.1M |
3/2021 | Genomics | Venture Round | 30M |
1/2016 | Mixergy Ltd. | Seed Round | - |
1/2020 | OxMet Technologies | Series B | 14.1M |
1/2018 | Pepgen | Seed Round | - |
7/2019 | Zegami | Series B | 1.6M |
11/2017 | Quantum Motion Technologies | Seed Round | - |
11/2015 | Bodle Technologies | Seed Round | - |
10/2016 | Argonaut Therapeutics | Seed Round | - |
7/2021 | Orbit Discovery | Venture Round | 0 |
12/2016 | Circadian Therapeutics | Venture Round | 2.5M |
4/2020 | BibliU | Series A | 10M |
12/2021 | ONI | Series B | 75M |
6/2015 | OxStem | Seed Round | - |
6/2018 | BibliU | Seed Round | 3.8M |
3/2021 | Caristo Diagnostics | Venture Round | - |
2/2017 | BibliU | Seed Round | 1.4M |
7/2018 | ONI | Series A | 24M |
2/2020 | Oxford VR | Series A | 0 |
10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
8/2019 | MoA Technology | Series A | 7.6M |
11/2022 | Util | Seed Round | 0 |
6/2018 | Metaboards | Series A | 0 |
7/2020 | PQShield | Seed Round | 6.9M |
4/2018 | Oxford Flow | Venture Round | 8.5M |
7/2016 | Oxford Impedance Diagnostics Ltd. | Seed Round | 2.6M |
1/2021 | Living Optics | Seed Round | 0 |
5/2018 | Orbit Discovery | Series A | 0 |
11/2017 | First Light Fusion | Venture Round | - |
1/2017 | Oxford VR | Seed Round | - |
10/2018 | Animal Dynamics | Series A | 0 |
5/2018 | Ultromics | Series A | 0 |
6/2022 | BibliU | Series B | 0 |
9/2018 | Evox Therapeutics | Series B | 0 |
12/2021 | Navenio | Venture Round | 0 |
7/2019 | Zegami | Series B | 1.6M |
7/2021 | Rey | Series A | 10M |
4/2023 | Caristo Diagnostics | Series A | 0 |
3/2023 | Mixergy | Venture Round | 0 |
3/2023 | Quantrol Ox | Seed Round | 0 |
2/2023 | Archangel Lightworks | Seed Round | 0 |
12/2022 | BehaVR | Series B | 0 |
3/2018 | Xerion Healthcare | Venture Round | 2.8M |
3/2022 | Scenic Biotech | Series A | 0 |
1/2017 | Covatic | Seed Round | 896.6k |
6/2020 | Base Genomics | Seed Round | 11.3M |
1/2023 | Grey Wolf Therapeutics | Series B | 0 |
6/2023 | Beacon Therapeutics | Series A | 0 |
5/2018 | Opsydia | Seed Round | 2.5M |
2/2018 | Odqa Renewable Energy Technologies | Seed Round | 570.6k |
5/2016 | ONI | Seed Round | 1.7M |
12/2019 | Mixergy Ltd. | Series A | 0 |
9/2022 | Opsydia | Venture Round | 0 |
7/2020 | ORCA Computing | Pre Seed Round | - |
10/2019 | MiroBio | Series A | 33.2M |
5/2018 | PQShield | Seed Round | - |
6/2020 | Oxford Flow | Venture Round | 0 |
6/2022 | MiroBio | Series B | 0 |
8/2017 | Inkpath | Series A | - |
2/2018 | Latent Logic | Seed Round | 2M |
2/2021 | Evox Therapeutics | Series C | 96.7M |
4/2020 | Perspectum | Series B | 35.9M |
5/2018 | Util | Seed Round | 1.1M |
10/2018 | Covatic | Seed Round | 1.1M |
6/2019 | Oxford Semantic Technologies | Series A | 3.8M |
3/2021 | Vaccitech | Series B | 168M |
1/2023 | Amber Therapeutics | Seed Round | - |
12/2020 | DJS Antibodies | Venture Round | 0 |
3/2017 | Bodle Technologies | Seed Round | - |
6/2015 | Proxisense | Seed Round | - |
11/2017 | Albus Health | Convertible Note | 66.6k |
9/2016 | Iota Sciences | Seed Round | - |
6/2017 | Diffblue | Series A | 21.8M |
1/2022 | PQShield | Series A | 0 |
12/2020 | Pepgen | Series A | 45M |
8/2021 | Pepgen | Venture Round | 0 |
12/2015 | Navenio | Seed Round | 2.6M |
7/2022 | Brill Power | Series A | 0 |
5/2022 | Salience Labs | Seed Round | 11.5M |
3/2017 | SpyBiotech | Seed Round | 5M |
4/2023 | Caristo Diagnostics | Series A | 0 |
3/2023 | Mixergy | Venture Round | 0 |
3/2023 | Quantrol Ox | Seed Round | 0 |
2/2023 | Quantum Motion | Series B | 0 |
2/2023 | Archangel Lightworks | Seed Round | 0 |
1/2023 | Grey Wolf Therapeutics | Series B | 0 |
1/2023 | Amber Therapeutics | Seed Round | - |
1/2023 | Oxford Ionics | Series A | 0 |
12/2022 | BehaVR | Series B | 0 |
11/2022 | Osler Diagnostics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|